DATALYR

GLP-1 advertising: Meta and Google ad rules explained

How GLP-1 telehealth brands advertise on Meta and Google: LegitScript, 18+ targeting, restricted data, and measuring revenue the platforms can't see.

By DATALYR · · 3 min read

Contents

Can you advertise GLP-1 medications?

Yes, with conditions. On Meta, a telehealth provider or online pharmacy promoting GLP-1 prescriptions must be actively certified with LegitScript, get Meta's authorization, and target only adults in eligible countries where it's certified. On Google in the United States, telemedicine providers need LegitScript certification and online pharmacies need accreditation plus Google certification.

Ad approval is only half the problem. Meta and Google also limit what health data a GLP-1 site may send back, so the purchase signal campaigns usually optimize for can be partly or fully unavailable. This guide covers both.

GLP-1 ads on Facebook and Instagram

Meta treats prescription weight loss products under its drugs and pharmaceuticals policy. Its requirements for promoting prescription drugs:

  • Online pharmacies and telehealth providers must be actively certified with LegitScript, then request Meta's authorization.
  • Target only people in eligible countries (United States, Canada or New Zealand), only where you're certified, and only people 18 or older.
  • Include a disclaimer to consult a licensed health professional or obtain a valid prescription.
  • Ads that promote telehealth services in general, or that educate about a prescription drug, don't need written authorization.

Creative rules that still apply

Meta's health and wellness policy applies on top of the prescription rules. Weight loss ads can't attack someone's appearance, show close-ups of pinched fat, or promise specific outcomes within a set time without qualifiers.

The personal attributes policy rules out copy that implies the reader's weight or health, such as asking whether they have a condition. Lead with the program, the clinician access and the price, not the person.

GLP-1 ads on Google

Google's healthcare and medicines policy requires certification for online pharmacies and, in the United States, allows telemedicine providers accredited by LegitScript's Healthcare Merchant Certification Program. Google's unapproved substances list separately bans products containing hCG in relation to weight loss or weight control.

Health is also a sensitive interest category in Google's personalized advertising policy. When promoting in it you can't use advertiser-curated audiences such as Customer Match or your data segments. Google's customer data policy adds that you may not upload conversion information related to sensitive categories, which include purchases of prescription drugs, and that such conversions can't be used for measurement in enhanced conversions.

A note on compounded GLP-1s

The FDA states that compounded drugs are not FDA-approved. It determined that the tirzepatide shortage was resolved (confirming the decision after re-evaluation in December 2024) and that the semaglutide shortage was resolved in February 2025, and published the enforcement timelines that followed for compounders. Check what your product is and what you can claim with your own regulatory counsel before writing ads; platform certification does not settle it.

Example: optimizing for quiz starts picks the wrong campaign

Suppose Meta restricts purchase events on a hypothetical GLP-1 site, so two campaigns optimize for an upper-funnel event such as a started intake quiz. Each spends $10,000 in a month.

Campaign A produces 800 quiz starts and 40 first payments of $249: $9,960 in revenue, a 1.0× return. Campaign B produces 500 quiz starts and 60 first payments: $14,940, a 1.49× return. The platform sees A as the stronger campaign because it only sees quiz starts. Revenue measured in your own records shows B is worth more.

What the platform sees versus what the business earns

Campaign A

800 quiz starts · $9,960 revenue

40 × $249. Return: $9,960 ÷ $10,000 ≈ 1.0×.

Campaign B

500 quiz starts · $14,940 revenue

60 × $249. Return: $14,940 ÷ $10,000 ≈ 1.49×.

Illustrative numbers, not a customer result.

Measuring GLP-1 campaigns without sharing health data

The practical setup has two halves. Your own measurement ties every ad click to the payments that follow, including renewals and refunds, so budget decisions rest on revenue. What each platform receives is limited to what its policy and any notice allow.

DATALYR runs both halves. It attributes revenue from Stripe, Shopify and other payment sources to the campaign and ad. With health filtering on, it filters health-related fields from conversions and keeps its managed Meta, Google and TikTok browser pixels off. When a platform restricts events, you record the notice and DATALYR withholds them, while first-party collection continues.

Related articles.

See what really drives revenue.

Real-time attribution, analytics and conversions for every channel, campaign and ad, ready for your team and your agents.

Get started